These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30080925)

  • 21. Beginning of life ethics at the dawn of a new era of genome editing: are bioethical precepts and fast-evolving biotechnologies irreconcilable?
    Marinelli S; Del Rio A
    Clin Ter; 2020; 171(5):e407-e411. PubMed ID: 32901783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Getting serious about the challenge of regulating germline gene therapy.
    Caplan A
    PLoS Biol; 2019 Apr; 17(4):e3000223. PubMed ID: 31039143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Germline Genome Editing: An Assessment.
    Greely HT
    CRISPR J; 2019 Oct; 2(5):253-265. PubMed ID: 31599681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethical and regulatory issues in human gene editing: Chinese perspective.
    Lei R; Qiu R
    Biotechnol Appl Biochem; 2020 Nov; 67(6):880-891. PubMed ID: 33011985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What Should Clinicians Do to Engage the Public About Gene Editing?
    Alsaigh T; Nicholson L; Topol E
    AMA J Ethics; 2019 Dec; 21(12):E1089-1097. PubMed ID: 31876474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does human genome editing reinforce or violate human dignity?
    Segers S; Mertes H
    Bioethics; 2020 Jan; 34(1):33-40. PubMed ID: 31222790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shaping the CRISPR Gene-Editing Debate: Questions About Enhancement and Germline Modification.
    Johnston J
    Perspect Biol Med; 2020; 63(1):141-154. PubMed ID: 32063593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editing.
    Zeps N; Lysaght T; Chadwick R; Erler A; Foo R; Giordano S; San Lai P; Schaefer GO; Xafis V; Chew WL; Sugarman J
    Stem Cell Reports; 2021 Jul; 16(7):1652-1655. PubMed ID: 34214486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethical Considerations in the Manufacture, Sale, and Distribution of Genome Editing Technologies.
    Sugarman J; Shivakumar S; Rook M; Loring JF; Rehmann-Sutter C; Taupitz J; Reinhard-Rupp J; Hildemann S
    Am J Bioeth; 2018 Aug; 18(8):3-6. PubMed ID: 30133390
    [No Abstract]   [Full Text] [Related]  

  • 30. Regulating germline editing in assisted reproductive technology: An EU cross-disciplinary perspective.
    Nordberg A; Minssen T; Feeney O; de Miguel Beriain I; Galvagni L; Wartiovaara K
    Bioethics; 2020 Jan; 34(1):16-32. PubMed ID: 31877579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focusing on Human Rights: a framework for CRISPR germline genome editing ethics and regulation.
    Doxzen K; Halpern J
    Perspect Biol Med; 2020; 63(1):44-53. PubMed ID: 32063585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rogues and Regulation of Germline Editing.
    Charo RA
    N Engl J Med; 2019 Mar; 380(10):976-980. PubMed ID: 30650001
    [No Abstract]   [Full Text] [Related]  

  • 33. Heritable Genome Editing: Who Speaks for "Future" Children?
    Knoppers BM; Kleiderman E
    CRISPR J; 2019 Oct; 2(5):285-292. PubMed ID: 31599679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolving policy with science.
    Charo RA; Hynes RO
    Science; 2017 Mar; 355(6328):889. PubMed ID: 28254888
    [No Abstract]   [Full Text] [Related]  

  • 35. After the Storm - A Responsible Path for Genome Editing.
    Daley GQ; Lovell-Badge R; Steffann J
    N Engl J Med; 2019 Mar; 380(10):897-899. PubMed ID: 30649993
    [No Abstract]   [Full Text] [Related]  

  • 36. Ethical issues of CRISPR technology and gene editing through the lens of solidarity.
    Mulvihill JJ; Capps B; Joly Y; Lysaght T; Zwart HAE; Chadwick R;
    Br Med Bull; 2017 Jun; 122(1):17-29. PubMed ID: 28334154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene Editing: A View Through the Prism of Inherited Metabolic Disorders.
    Davison J
    New Bioeth; 2018 Apr; 24(1):2-8. PubMed ID: 29529978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One small edit for humans, one giant edit for humankind? Points and questions to consider for a responsible way forward for gene editing in humans.
    Howard HC; van El CG; Forzano F; Radojkovic D; Rial-Sebbag E; de Wert G; Borry P; Cornel MC;
    Eur J Hum Genet; 2018 Jan; 26(1):1-11. PubMed ID: 29192152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An ethical pathway for gene editing.
    Savulescu J; Singer P
    Bioethics; 2019 Feb; 33(2):221-222. PubMed ID: 30695116
    [No Abstract]   [Full Text] [Related]  

  • 40. Human Genome Editing and Ethical Considerations.
    Krishan K; Kanchan T; Singh B
    Sci Eng Ethics; 2016 Apr; 22(2):597-9. PubMed ID: 26154417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.